vs
Side-by-side financial comparison of CPI Card Group Inc. (PMTS) and Stoke Therapeutics, Inc. (STOK). Click either name above to swap in a different company.
Stoke Therapeutics, Inc. is the larger business by last-quarter revenue ($158.6M vs $153.1M, roughly 1.0× CPI Card Group Inc.). Stoke Therapeutics, Inc. runs the higher net margin — 71.2% vs 4.8%, a 66.4% gap on every dollar of revenue. On growth, Stoke Therapeutics, Inc. posted the faster year-over-year revenue change (3661.1% vs 22.3%). Stoke Therapeutics, Inc. produced more free cash flow last quarter ($131.7M vs $35.2M).
CPI Card Group Inc. is a leading provider of payment card production and associated solutions, including contactless and contact credit/debit cards, prepaid cards, and card personalization services. It primarily serves financial institutions, fintech firms, and retail brands across its core North American market.
Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.
PMTS vs STOK — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $153.1M | $158.6M |
| Net Profit | $7.3M | $112.9M |
| Gross Margin | 31.5% | — |
| Operating Margin | 12.0% | 70.2% |
| Net Margin | 4.8% | 71.2% |
| Revenue YoY | 22.3% | 3661.1% |
| Net Profit YoY | 8.5% | 528.0% |
| EPS (diluted) | $0.62 | $1.90 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $153.1M | — | ||
| Q3 25 | $138.0M | — | ||
| Q2 25 | $129.8M | — | ||
| Q1 25 | $122.8M | $158.6M | ||
| Q4 24 | $125.1M | $22.6M | ||
| Q3 24 | $124.8M | — | ||
| Q2 24 | $118.8M | — | ||
| Q1 24 | $111.9M | — |
| Q4 25 | $7.3M | — | ||
| Q3 25 | $2.3M | — | ||
| Q2 25 | $518.0K | — | ||
| Q1 25 | $4.8M | $112.9M | ||
| Q4 24 | $6.8M | $-10.5M | ||
| Q3 24 | $1.3M | — | ||
| Q2 24 | $6.0M | — | ||
| Q1 24 | $5.5M | — |
| Q4 25 | 31.5% | — | ||
| Q3 25 | 29.7% | — | ||
| Q2 25 | 30.9% | — | ||
| Q1 25 | 33.2% | — | ||
| Q4 24 | 34.1% | — | ||
| Q3 24 | 35.8% | — | ||
| Q2 24 | 35.7% | — | ||
| Q1 24 | 37.1% | — |
| Q4 25 | 12.0% | — | ||
| Q3 25 | 9.4% | — | ||
| Q2 25 | 7.3% | — | ||
| Q1 25 | 11.5% | 70.2% | ||
| Q4 24 | 12.7% | -60.4% | ||
| Q3 24 | 14.3% | — | ||
| Q2 24 | 12.5% | — | ||
| Q1 24 | 12.6% | — |
| Q4 25 | 4.8% | — | ||
| Q3 25 | 1.7% | — | ||
| Q2 25 | 0.4% | — | ||
| Q1 25 | 3.9% | 71.2% | ||
| Q4 24 | 5.4% | -46.4% | ||
| Q3 24 | 1.0% | — | ||
| Q2 24 | 5.1% | — | ||
| Q1 24 | 4.9% | — |
| Q4 25 | $0.62 | — | ||
| Q3 25 | $0.19 | — | ||
| Q2 25 | $0.04 | — | ||
| Q1 25 | $0.40 | $1.90 | ||
| Q4 24 | $0.56 | $-0.15 | ||
| Q3 24 | $0.11 | — | ||
| Q2 24 | $0.51 | — | ||
| Q1 24 | $0.46 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $21.7M | $274.8M |
| Total DebtLower is stronger | $286.7M | — |
| Stockholders' EquityBook value | $-17.3M | $350.1M |
| Total Assets | $403.2M | $406.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $21.7M | — | ||
| Q3 25 | $16.0M | — | ||
| Q2 25 | $17.1M | — | ||
| Q1 25 | $31.5M | $274.8M | ||
| Q4 24 | $33.5M | $128.0M | ||
| Q3 24 | $14.7M | — | ||
| Q2 24 | $7.5M | — | ||
| Q1 24 | $17.1M | — |
| Q4 25 | $286.7M | — | ||
| Q3 25 | $308.4M | — | ||
| Q2 25 | $310.9M | — | ||
| Q1 25 | $280.7M | — | ||
| Q4 24 | $280.4M | — | ||
| Q3 24 | $280.2M | — | ||
| Q2 24 | $269.7M | — | ||
| Q1 24 | $265.3M | — |
| Q4 25 | $-17.3M | — | ||
| Q3 25 | $-25.7M | — | ||
| Q2 25 | $-29.0M | — | ||
| Q1 25 | $-29.7M | $350.1M | ||
| Q4 24 | $-35.6M | $229.0M | ||
| Q3 24 | $-42.8M | — | ||
| Q2 24 | $-44.6M | — | ||
| Q1 24 | $-48.5M | — |
| Q4 25 | $403.2M | — | ||
| Q3 25 | $407.1M | — | ||
| Q2 25 | $399.8M | — | ||
| Q1 25 | $351.9M | $406.9M | ||
| Q4 24 | $349.7M | $271.6M | ||
| Q3 24 | $342.3M | — | ||
| Q2 24 | $321.4M | — | ||
| Q1 24 | $319.8M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $39.6M | $131.8M |
| Free Cash FlowOCF − Capex | $35.2M | $131.7M |
| FCF MarginFCF / Revenue | 23.0% | 83.0% |
| Capex IntensityCapex / Revenue | 2.9% | 0.1% |
| Cash ConversionOCF / Net Profit | 5.39× | 1.17× |
| TTM Free Cash FlowTrailing 4 quarters | $41.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $39.6M | — | ||
| Q3 25 | $10.0M | — | ||
| Q2 25 | $4.3M | — | ||
| Q1 25 | $5.6M | $131.8M | ||
| Q4 24 | $26.7M | $-23.2M | ||
| Q3 24 | $12.5M | — | ||
| Q2 24 | $-4.8M | — | ||
| Q1 24 | $8.9M | — |
| Q4 25 | $35.2M | — | ||
| Q3 25 | $5.3M | — | ||
| Q2 25 | $533.0K | — | ||
| Q1 25 | $292.0K | $131.7M | ||
| Q4 24 | $21.6M | $-23.2M | ||
| Q3 24 | $11.1M | — | ||
| Q2 24 | $-6.0M | — | ||
| Q1 24 | $7.4M | — |
| Q4 25 | 23.0% | — | ||
| Q3 25 | 3.8% | — | ||
| Q2 25 | 0.4% | — | ||
| Q1 25 | 0.2% | 83.0% | ||
| Q4 24 | 17.3% | -102.7% | ||
| Q3 24 | 8.9% | — | ||
| Q2 24 | -5.0% | — | ||
| Q1 24 | 6.6% | — |
| Q4 25 | 2.9% | — | ||
| Q3 25 | 3.4% | — | ||
| Q2 25 | 2.9% | — | ||
| Q1 25 | 4.3% | 0.1% | ||
| Q4 24 | 4.0% | 0.2% | ||
| Q3 24 | 1.2% | — | ||
| Q2 24 | 1.0% | — | ||
| Q1 24 | 1.3% | — |
| Q4 25 | 5.39× | — | ||
| Q3 25 | 4.32× | — | ||
| Q2 25 | 8.39× | — | ||
| Q1 25 | 1.17× | 1.17× | ||
| Q4 24 | 3.94× | — | ||
| Q3 24 | 9.70× | — | ||
| Q2 24 | -0.79× | — | ||
| Q1 24 | 1.63× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PMTS
| US Debit And Credit | $128.9M | 84% |
| US Prepaid Debit | $24.4M | 16% |
STOK
Segment breakdown not available.
